Auzone Biological Technology Pty Ltd Report issue

For profit Phase 1
Founded: Thornleigh Australia (2019)

Organization Overview

First Clinical Trial
2020
NCT04370431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Auzone Biological Technology Pty Ltd

Active Ingredients

Drugs in Phase 1 Trials (1)

edaravone (radicava) (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1